Analysts have set an implied target price of $57.72 for the SPDR S&P 500 Fossil Fuel Reserves Free ETF (SPYX), which currently trades at $52.05, indicating a potential upside of 10.88%. This analysis is based on the average 12-month target prices of the ETF’s underlying holdings.
Among SPYX’s underlying holdings, Zoetis Inc (ZTS) shows a 32.81% upside, with a recent price of $146.50 compared to an average target of $194.57. Regeneron Pharmaceuticals, Inc. (REGN) trading at $555.13 has a potential upside of 32.73% to a target of $736.83. Healthpeak Properties Inc (DOC) is priced at $16.85, with a target of $22.06, suggesting a 30.93% upside.
| Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
|---|---|---|---|---|
| SPDR S&P 500 Fossil Fuel Reserves Free ETF | SPYX | $52.05 | $57.72 | 10.88% |
| Zoetis Inc | ZTS | $146.50 | $194.57 | 32.81% |
| Regeneron Pharmaceuticals, Inc. | REGN | $555.13 | $736.83 | 32.73% |
| Healthpeak Properties Inc | DOC | $16.85 | $22.06 | 30.93% |
